American Portfolios Advisors’s Corbus Pharmaceuticals CRBP Stock Holding History

American Portfolios Advisors’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$381	Buy	77 +3	+4%	+$21	﹤0.01%	3417
2022 Q2	$558	Hold	74	–	–	﹤0.01%	3377
2022 Q1	$1.18K	Hold	74	–	–	﹤0.01%	3336
2021 Q4	$1.36K	Hold	74	–	–	﹤0.01%	3268
2021 Q3	$2.26K	Hold	74	–	–	﹤0.01%	3129
2021 Q2	$4.05K	Hold	74	–	–	﹤0.01%	2911
2021 Q1	$4.36K	Hold	74	–	–	﹤0.01%	2752
2020 Q4	$2.77K	Hold	74	–	–	﹤0.01%	2616
2020 Q3	$3.98K	Sell	74 -20	-21%	-$3.62K	﹤0.01%	2370
2020 Q2	$23.6K	Hold	94	–	–	﹤0.01%	1574
2020 Q1	$14.7K	Buy	94 +20	+27%	+$3.38K	﹤0.01%	1653
2019 Q4	$12.1K	Hold	74	–	–	﹤0.01%	1920
2019 Q3	$10.8K	Buy	+74	New	+$12.9K	﹤0.01%	1906

Other funds holding CRBP

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Portfolios Advisors's CRBP Position: Q3 2022 in Review

American Portfolios Advisors increased its Corbus Pharmaceuticals (CRBP) stake by 4.1% in Q3 2022, buying an estimated $21 and bringing the position to 77 shares worth $381. The position accounts for ﹤0.01% of the portfolio, ranked #3417.

American Portfolios Advisors first reported a position in CRBP in Q3 2019 and has held it in 13 quarters since. The position peaked at $23.6K in Q2 2020. 64 funds tracked by Wall St. Rank hold CRBP as of Q3 2022.

American Portfolios Advisors held 77 shares of Corbus Pharmaceuticals worth $381 as of Q3 2022.
American Portfolios Advisors bought 3 Corbus Pharmaceuticals shares in Q3 2022, an estimated $21.
Corbus Pharmaceuticals made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3417 holding.
American Portfolios Advisors first reported a position in Corbus Pharmaceuticals in Q3 2019 and has held it in 13 quarters since.
American Portfolios Advisors's Corbus Pharmaceuticals position peaked at $23.6K in Q2 2020.
64 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.